In this study, we investigated the role of the amino acid residues in the COOH terminus of the human P2Y1 receptor in Gq activation. Stimulation of Chinese hamster ovary (CHO-K1) cells stably expressing the wild-type human P2Y1 receptor (P2Y1-WT cells), P2Y1-⌬R340-L373, or P2Y1-⌬D356-L373 with 2-methylthio-ADP (2-MeSADP) caused inositol phosphate production. In contrast, cells expressing P2Y1-⌬T330-L373, a mutant lacking the entire COOH terminus, completely lost their response to 2-MeSADP. Similar data were obtained by using these cell lines and measuring Ca 2ϩ mobilization upon stimulation with 2-MeSADP, indicating that the 10 amino acids (330TFRRRLSRAT339) in the COOH terminus of the human P2Y1 receptor are essential for Gq coupling. Radioligand binding demonstrated that both the P2Y1-WT and P2Y1-⌬T330-L373-expressing cells have almost equal binding of [ 3 H]MRS2279, a P2Y 1 receptor antagonist, indicating that COOH-terminal truncation did not drastically affect the conformation of the receptor. CHO-K1 cells expressing a chimeric P2Y12 receptor with the P2Y1 COOH terminus failed to elicit Gq functional responses, indicating that the P2Y1 COOH terminus is essential but not sufficient for Gq activation. Finally, cells expressing a double-mutant P2Y1 receptor (R333A/R334A) in the conserved BBXXB region of the COOH terminus of the Gq-activating P2Y receptors completely lost their functional ability to activate Gq. We conclude that the two arginine residues (R333R334) in the COOH terminus of the human P2Y1 receptor are essential for Gq coupling. carboxyl terminus; adenosine diphosphate; truncation; inositol phosphate EXTRACELLULAR NUCLEOTIDES influence many biological functions, including vascular tone, cell division, cardiac and skeletal muscle contraction, and platelet aggregation, as well as peripheral and central neurotransmission (7). Extracellular nucleotides can trigger intracellular effects by specifically binding to and activating cell surface membrane proteins known as P2 receptors (7, 14, 15, 18) . Two main families of receptors for extracellular nucleotides have been described: P2X receptors, which are ligand-gated ion channels, and P2Y receptors, which belong to the superfamily of G protein-coupled receptors (7). Nine distinct P2Y receptors are expressed in human tissues: P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , P2Y 14 , and P2Y 15 (1, 7, 14, 27) . However, the P2Y 15 receptor might indeed be a receptor for ␣-ketoglutarate (23).
The human P2Y 1 receptor was originally cloned from human erythroleukemia cells (4) and endothelial cells (37) . The human P2Y 1 receptor is 373 amino acids long with 7 putative hydrophobic transmembrane regions and is encoded by a single exon (3) . The gene for the human P2Y 1 receptor has been localized to chromosome 3q25 (3) . When heterologously expressed in astrocytoma cells, the P2Y 1 receptor has been shown to activate PLC through pertussis toxin-insensitive G proteins of the G q/11 class, resulting in inositol phosphate formation (44) . Studies with mice lacking G q revealed that signaling through G q is essential for ADP-induced functional responses in platelets (40) .
ADP and 2-methylthio-ADP (2-MeSADP) are potent agonists at the P2Y 1 receptor, whereas adenosine 3Ј-phosphate 5Ј-phosphosulfate, adenosine 3Ј-phosphate 5Ј-phosphate, and adenosine 2Ј-phosphate 5Ј-phosphate are selective antagonists (6) . Mutational analysis studies have been performed to locate the essential residues for ligand recognition, identifying several amino acids in the extracellular loops and transmembrane domains that were essential for ligand recognition (25, 28) . P2Y 1 was the first P2Y receptor to be cloned and has a wide distribution, having been described in heart, vascular, connective, immune, and neural tissues (43) . P2Y 1 receptors may be involved in the modulation of neurotransmission (48) . However, the function of the P2Y 1 receptor has been studied most extensively in platelets (33) . The P2Y 1 receptor plays an important role in ADP-induced shape change (29) , aggregation (30) , and thromboxane A 2 (TXA 2 ) generation (31) . P2Y 1 receptor-deficient mice have increased bleeding times and are protected from thromboembolism (19, 36) . These results suggest that the P2Y 1 signaling blockade, at the receptor-G protein interaction level, might be a potential antithrombotic drug target. With this goal in mind, we initiated studies to elucidate the G q coupling domains in the P2Y 1 receptor.
In this study, we first sought to explore the role of the COOH-terminal region of human P2Y 1 receptor in receptormediated G q activation and found that the COOH terminus is critical for the G q coupling ability of the receptor. Furthermore, we also identified two arginine residues (R333R334) in the COOH-terminal region that are essential for G q coupling. Construction of human P2Y 1 truncation mutant plasmids. Human platelet P2Y1 receptor (GenBank accession no. U42029) (3) was cloned into the pcDNA3 vector with a HA tag (YPYDVPDYA) inserted at the beginning of the translation initiation by polymerase chain reaction (PCR). Forward primer containing a BamHI restriction site (underlined) and a HA tag sequence was 5Ј-GCGGATCCACCATGTACCCATAC-GATGTTCCAGATTACGCTACCGAGGTGCTGTGGCCGGCT-3Ј. Three COOH-terminally truncated P2Y 1 receptors (P2Y1-⌬T330-L373, P2Y 1-⌬R340-L373, and P2Y1-⌬D356-L373) were constructed using PCR with the same forward primer (as for wild-type P2Y 1), a reverse primer with a stop codon at the desired location ( Fig. 1 and Table 1) , and an XhoI restriction site to aid in subcloning. All truncated receptors were subcloned into pcDNA3 and verified using DNA sequence analysis.
MATERIALS AND METHODS

Materials. 2-MeSADP was obtained from
Construction of human P2Y 12/P2Y1 chimeric receptor expression plasmid. One human P2Y 12/P2Y1 chimera was constructed using overlap-extension PCR with the COOH terminus of human platelet P2Y 12 receptor (GenBank accession no. AF313449) (26) replaced by human P2Y 1 receptor (GenBank accession no. U42029). With the use of human P2Y12 in pcDNA3.1/Hygro(ϩ) (13) as template, the first part of the chimera was PCR amplified using forward primer containing a KpnI restriction site (underlined) and the HA tag sequence (designated primer I), 5Ј-GCGCGGTACCACCATGTACCCATAC-GATGTTCCAGATTACGCTCAAGCCGTCGACAATCTC-3Ј; the reverse primer that matched both parts (designated primer II) was 5Ј-AGTCTCCTTCTGAAAGTCTTGCAAAGGAAAAAATA-3Ј. For the second part of the chimera, human platelet P2Y 1 receptor in pcDNA3 was used as template. The forward primer that matched both parts (designated primer III) was 5Ј-ATTTTTTCCTTTGCAA-GACTTTCAGAAGGAGACTC-3Ј, and the reverse primer containing a XhoI restriction site (designated primer IV) was 5Ј-GCCTCGAGCAGGCTTGTATCTCCATTCTGC-3Ј. After confirmation that the two parts were successfully amplified, 1 l of each part used as template was added in a 50-l reaction volume, and the second cycle of PCR was performed by using primer I as forward primer and primer IV as reverse primer to amplify the full length of the chimera P2Y 12/P2Y1. The overlap-extension PCR-amplified P2Y 12/P2Y1 was then cloned into pcDNA3 by digesting the PCR product with KpnI and XhoI and inserted into the vector digested with the same set of restriction enzymes. The nucleotide sequence of the P2Y 12/P2Y1 receptor coding sequence in the expression plasmid was confirmed using DNA sequence analysis.
Construction of P2Y 1-R333A/R334A expression plasmid. Human P2Y 1-R333A/R334A expression plasmid was constructed using wildtype human P2Y 1 receptor expression plasmid as template by performing site-directed mutagenesis as described previously (13), using forward primer 5Ј-GGGAGATACTTTCAGAGCGGCACTCTC-CCGAGCCACAAGG-3Ј and reverse primer 5Ј-CCTTGTGGCTCG-GGAGAGTGCCGCTCTGAAAGTATCTCCC-3Ј. The nucleotide sequence of the P2Y 1-R333A/R334A encoding sequence in the expression plasmid [P2Y 1-R333A/R334A-pcDNA3/G418(ϩ)] was confirmed using DNA sequence analysis.
Cell culture. Chinese hamster ovary (CHO-K1) cells were grown in Ham's F-12 medium (Mediatech, Herndon, VA) supplemented with 10% fetal bovine serum and 1% penicillin, streptomycin, and amphotericin B at 37°C with 5% CO 2. CHO-K1 cells transfected with wild-type or mutant P2Y 1 receptors were grown in the same medium supplemented with 500 g/ml G418.
Stable expression of human P2Y 1 receptor in CHO-K1 cells. The expression construct for the wild-type P2Y 1 receptor or for each of the P2Y 1 mutants (1 g) was used to transfect CHO-K1 cells by using Lipofectamine as described previously (2) . After 6 h, the growth medium was replaced with fresh medium. Stable transfectants were selected on medium containing 500 g/ml G418 and were screened for the expression of wild-type or mutant P2Y 1 receptor by HA tag detection using flow cytometry.
HA tag detection using flow cytometry. CHO-K1 cells, naive, vector transfected, or stably transfected with P2Y 1 receptors, were cultured in 100-mm dishes, washed twice with PBS (137 mM NaCl, 2.68 mM KCl, 4.29 mM Na 2HPO4, and 1.47 mM KH2PO4) and detached with Versene (0.5 mM Na 4EDTA, 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2HPO4, 15 mM KH2PO4, and 1 mM glucose). After spinning at 700 rpm for 3 min, the pellets were resuspended in Tyrode solution [137 mM NaCl, 2.67 mM KCl, 2 mM MgCl 2, 2.03 mM cells/ml. Aliquots of 100 l of cell suspension were mixed with 4 l of 1:10 diluted FITC-labeled monoclonal antibody against HA (Covance) in the presence of 2 mM Ca 2ϩ . After incubation at 4°C for 1 h in the dark, cell suspensions were briefly spun, and the supernatant was discarded. Cells were resuspended in 400 l of Tyrode solution and analyzed using flow cytometry with FACScan (BD Biosciences). Untransfected CHO-K1 cells were used as negative control.
Measurement of inositol phosphate levels. Inositol phosphate levels were measured as described previously with minor modifications (13, 20, 32) . Confluent cultures of cells in 12-well plates were labeled with 1 Ci/ml (0.037 MBq/ml) myo-2-[
3 H]inositol in inositol-free DMEM for 16 -24 h. Labeled cells were washed once, the medium was replaced with 970 l of fresh inositol-free DMEM containing 20 l of 1 M LiCl, and the cells were incubated at 37°C for 15 min. The cells were then stimulated with 10 l of 2-MeSADP (varying concentrations) for 10 min, and the reaction was terminated by aspiration of the medium, addition of 0.75 ml of 10 mM formic acid, and incubation at room temperature for 45 min. The solution containing the extracted inositol phosphates was neutralized by dilution with 3 ml of 5 mM NH 4OH (yielding a final pH of 8 -9) and then applied directly to a column containing 0.7 ml of the anion exchange resin AG 1-X8 (Bio-Rad, Hercules, CA), equilibrated with 40 mM ammonium formate. The column was washed with 4 ml of 40 mM ammonium formate, pH 5.0, to remove the free inositol and the glyceroinositol. Total inositol phosphates were eluted with 4 ml of 2 M ammonium formate, pH 5.0. The eluate (1 ml) was removed and counted with 9 ml of scintillation fluid.
Measurement of cytoplasmic free Ca 2ϩ concentration. Cultured cells were harvested and incubated for 45 min at room temperature in Hanks' buffered salt solution (HBSS; Mediatech) containing 1 M fura-2 AM (Molecular Probes, Eugene, OR) and 0.2% BSA. Cells were washed twice and then resuspended in HBSS containing 0.2% BSA, and cytoplasmic free Ca 2ϩ concentration was measured as previously described (46) . Briefly, aliquots of 0.7 ml of cell suspension were placed in disposable methacrylate cuvettes under stirring conditions at 37°C. Fluorescence was recorded on an Aminco-Bowman spectrofluorometer (Spectronics Instruments, Rochester, NY) during agonist stimulation by using alternating excitation wavelengths of 340 and 380 nm and monitoring emitted light at 510 nm. Cytoplasmic concentrations of Ca 2ϩ were calculated according to Tsien's ratiometric method (22) .
Radioligand binding assay. Binding of the high-affinity P2Y 1 receptor antagonist (5) [ 3 H]MRS2279 to wild-type or truncated P2Y1 receptors was performed as described elsewhere (49) . Briefly, cell membranes (125 g of protein) were incubated at 4°C with 30 nM [ 3 H]MRS2279 (ϳ120,000 cpm) in 20 mM Tris, pH 7.5, 145 mM NaCl, and 5 mM MgCl2 in a volume of 50 l. Specific binding was usually defined as total [ 3 H]MRS2279 binding minus binding occurring in the presence of a 10 M concentration of the P2Y1 receptorspecific antagonist MRS2179. Incubations proceeded for 30 min at 4°C. Binding reactions were terminated by addition of 4 ml of ice-cold wash buffer (10 mM Tris, pH 7.5 at 4°C, and 145 mM NaCl) and rapid filtration over GF/A glass fiber filters. Each filter was washed with an additional 4 ml of ice-cold wash buffer. Radioactivity was quantitated using liquid scintillation spectrometry.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical significance was determined using Student's t-test and was designated at P values Ͻ0.05.
RESULTS AND DISCUSSION
Stable expression of P2Y 1 wild-type and COOH-terminal truncations in CHO-K1. Different constructs of the human P2Y 1 receptor (outlined in Fig. 1 ) were prepared as described in MATERIALS AND METHODS. CHO-K1 cells were transfected with the P2Y 1 wild-type receptor and mutants, and clones resistant to 500 g/ml G418 were selected. We screened the clones on the basis of HA tag expression on the cell surface as detected by flow cytometry using a FITC-labeled monoclonal antibody against an HA tag located at the NH 2 terminus of the receptor. Transfected cells were cultured in the presence of 500 g/ml G418 for 14 days, and then cells expressing the HA tag were sorted using a Cytomation MoFlo (Fort Collins, CO) before proceeding with the single-cell cloning process. The successful expression of the wild-type and mutant P2Y 1 receptors in CHO-K1 cells was confirmed by HA tag detection using flow cytometry ( Fig. 2A and Table 2 ). All cell lines expressing COOH-terminally truncated P2Y 1 receptors showed equal or higher levels of expression of the HA tag compared with cells expressing the wild-type P2Y 1 receptor.
COOH-terminal truncation abolished G q activation by P2Y 1 receptor. 2-MeSADP, a human platelet P2Y 1 receptor agonist, concentration-dependently activated the wild-type P2Y 1 receptor (P2Y 1 -WT) that was stably expressed in CHO-K1 cells and resulted in the production of inositol phosphates ( Fig. 2A) and intracellular Ca 2ϩ mobilization (Fig. 2B) . P2Y 1 -⌬T330-L373 stably expressed in CHO-K1 cells did not respond to 2-Me-SADP up to 1 M in concentration (Fig. 2, A and B) . The EC 50 values for inositol phosphate production and for intracellular Ca 2ϩ mobilization are summarized in Table 2 . We determined that the COOH-terminal truncation did not affect receptor expression on the surface of CHO-K1 cells ( Fig. 2A and Table  2 ). Hence, abolished cellular responses in P2Y 1 deletion mutant in response to 2-MeSADP are not due to low expression levels of the P2Y 1 receptor and are likely due to loss of an important domain necessary for coupling to G q .
[ terminus is a G q -coupling region that is crucial for the interaction between G q and the P2Y 1 receptor.
P2Y 1 receptor COOH terminus is not sufficient for G q activation. Because deletion of the COOH terminus of the P2Y 1 receptor resulted in the complete loss of G q activation, we investigated whether this domain is the G q coupling domain in the P2Y 1 receptor. We achieved this by constructing an expression plasmid for a chimeric P2Y 12 receptor in which the coding sequence for the COOH terminus was replaced with that for the human P2Y 1 receptor (Fig. 4A) . The P2Y 12 receptor has the same agonist profile as the P2Y 1 receptor and activates G i but not G q (33) . We reasoned that if the COOH terminus of the P2Y 1 receptor is sufficient for activation of G q , then the chimeric P2Y 12 /P2Y 1 should stimulate PLC upon stimulation with ADP. As shown in Fig. 4B , inset, the chimeric receptor is expressed on the surface as detected by HA tag in CHO-K1 cells transfected with the expression plasmid. However, these cells stably expressing the chimeric receptor failed to stimulate G q , as evidenced by a lack of increases in inositol phosphate generation (Fig. 4B) or increased intracellular Ca 2ϩ mobilization (not shown). The chimeric P2Y 12 /P2Y 1 receptor still retained the G i stimulating ability with an EC 50 value similar to that of wild-type P2Y 12 when 2-MeSADP-induced adenylyl cyclase was measured (data not shown).
COOH-terminal truncation at R340 and D356 did not abolish coupling of P2Y 1 to G q protein.
The COOH terminus of the human P2Y 1 receptor is composed of 44 amino acids, and this region appears to be critical for coupling to G q . To more precisely locate the specific domain responsible for G q coupling, we specifically truncated the COOH terminus of P2Y 1 at different sites and constructed two additional human platelet P2Y 1 truncations, P2Y 1 -⌬R340-L373 and P2Y 1 -⌬D356-L373 (see Fig. 1 ), which were expressed in CHO-K1 cells. The successful expression of these two truncated P2Y 1 receptors was confirmed by detection of the HA tag on the surface of CHO-K1 cells (Fig. 5, inset, and Table 2 ). The function of these two truncations was evaluated by assaying the production of inositol phosphate and the mobilization of intracellular Ca 2ϩ upon stimulation with 2-MeSADP. In contrast to its effect in the cell line expressing the P2Y 1 -⌬T330-L373 receptor, 2-Me-SADP concentration-dependently activated PLC in CHO-K1 cells stably expressing P2Y 1 -⌬R340-L373 and P2Y 1 -⌬D356-L373 (Fig. 5, A and B) . The concentration-response curves for . A sequence of 10 amino acids in the T330-T339 domain of P2Y1 COOH terminus is conserved in human and 5 other species (bovine, guinea pig, rat, mouse, chicken) (11, 12, 24, 42, 45, 50) . The high consensus of amino acids may be related to the requirement of this domain for Gq activation. Amino acids that are different among species are shown in bold type (A). The 10-amino acid sequence T330-T339 is not conserved in other human P2Y receptors. The putative Gq-interacting motif B-B-X-X-B is shown in bold type (B). The total number of amino acids in each P2Y receptor is shown at right (B). the mutants were shifted slightly to the right, and the corresponding EC 50 values for production of inositol phosphate (Fig. 5A) and Ca 2ϩ mobilization (Fig. 5B) were slightly higher compared with those for the cell line expressing the P2Y 1 -WT receptor (Table 2 ). These results suggest that the domain between R340 and L373 is not essential in conferring the G q -coupling ability to the P2Y 1 receptor. We therefore conclude that the 10-amino acid segment between T330 and T339 (TFRRRLSRAT) in the COOH terminus of the P2Y 1 receptor is crucial for coupling to the G q protein.
Previous studies have shown that the COOH terminus of the P2Y 1 receptor also regulates the inactivation gating of an ion channel in oocytes (35) . The domain involved in this interaction has been delineated by deletion mutagenesis (35) . These studies identified a short region, R340-L359, in the COOH terminus of the P2Y 1 receptor interacting with this ion channel (35) . In contrast, deletion of R340 to L373 did not affect the G q -activating ability of the P2Y 1 receptor (Fig. 5) . Thus the domains interacting with the oocyte ion channel and the G q protein are distinct in the COOH terminus of the P2Y 1 receptor. Comparison of the COOH-terminal sequence of the human P2Y 1 receptor with the P2Y 1 receptor COOH-terminal sequence of other species revealed regions of high consensus (Fig. 6A) . The human P2Y 1 COOH terminus has 97.7% identity with that of bovine and guinea pig, 95.4% identity with that of rat and mouse, and 86.3% with that of chicken. Among the three domains of human P2Y 1 receptor COOH terminus investigated in this study (T330-T339, R340-E355, and D356-L373), only the first 10 amino acids in the T330-T339 domain of P2Y 1 COOH terminus for human and the other five species (bovine, guinea pig, rat, mouse, and chicken) are 100% identical. The high consensus of amino acids of this domain may be related to the requirement of this domain in G q activation. It is noteworthy that this region (T330-T339) also contains the BBXXB motif (where B is a basic residue and X is a non-basic residue) that is frequently involved in G q coupling (34) . The two consecutive arginine residues of the BBXXB also exist in the other G q -coupled human P2Y receptors such as P2Y 4 and P2Y 6 (Fig. 6B ). This implies that these two arginine residues, Arg333 and Arg334, may be critically important for P2Y receptor-mediated G q activation.
Role of Arg333 and Arg334 residues in the P2Y 1 receptor in G q coupling. Site-directed mutagenesis was performed to determine whether these two arginine residues are indeed critical for recognition of G q by P2Y 1 receptor. A double mutant of human P2Y 1 receptor plasmid was generated wherein these two arginine residues were mutated to alanine. The construct was transfected into CHO-K1 cells, and two clones expressing the receptor were selected. As shown in Fig. 7A , inset, the D3 clone is expressed at lower levels than the wild-type receptor in the P2Y 1 -WT clone, whereas the G12 clone is expressed at higher levels. The functional evaluation was performed in these cells upon stimulation with 2-MeSADP. As shown in Fig.  7A , neither of these double-mutant P2Y 1 receptor-expressing cells caused any inositol phosphate generation in response to 2-MeSADP. Similarly, 2-MeSADP failed to cause any mobilization of Ca 2ϩ from intracellular stores in these cells expressing the double-mutant P2Y 1 receptors (Fig. 7B ). These data demonstrate the importance of the Arg333 and Arg334 residues in G q activation by the P2Y 1 receptor.
The P2Y 2 receptor was originally known as the P2U receptor and was shown to couple to pertussis toxin-sensitive G proteins (15) (16) (17) (18) 42) . However, the presence of BBXXB sequence in the COOH terminus of the P2Y 2 receptor (highlighted in bold in Fig. 6B ) suggests that this receptor might activate pertussis toxin-insensitive G proteins as well. Thus the P2Y 2 receptor might couple to both pertussis toxin-sensitive and -insensitive G proteins. Consistent with this notion, pertussis toxin only partially inhibits P2Y 2 receptor-mediated intracellular Ca 2ϩ mobilization (38, 42) . Previously, Weisman and coworkers (21, 41) generated truncated mutants of the P2Y 2 receptor and studied their ability to be desensitized. These truncations in the COOH terminus of the P2Y 2 receptor are similar to P2Y 1 -⌬R340-L373 and P2Y 1 -⌬D356-L373. Similar to the P2Y 1 truncations, the P2Y 2 truncations in the COOH terminus retained their ability to couple to the G proteins. However, these investigators have not deleted the HRPNR (BBXXB) from the murine P2Y 2 receptor, and hence it is not clear whether these amino acids in the P2Y 2 receptor are also important for G q protein coupling (21, 41) . Future studies are needed to evaluate these possibilities.
The P2Y 12 , P2Y 13 , and P2Y 14 receptors couple to pertussis toxin-sensitive G proteins (8, 26, 52, 53) . The functional effects of these three receptors are abolished by pertussis toxin treatment (8, 26, 53) . These data and the lack of BBXXB motif in the COOH termini of these receptors (Fig. 6B) are consistent with their inability to activate the G q class of proteins. Finally, the P2Y 11 and P2Y 15 receptors couple to both G q and G s proteins (10, 27) but lack the BBXXB motif in their COOH termini (Fig. 6B) . It is possible that these two receptors use some other motif for G q coupling.
The BB motif in BBXXB is found not only in P2Y but also in other G q -coupled receptors. Human TXA 2 receptor contains two consecutive arginine residues at the juxtamembrane COOH terminus (47) . Moreover, three human ␣ 1A -adrenergic receptor isoforms (␣ 1A-1 , ␣ 1A-2 , and ␣ 1A-3 ) (9) as well as the human platelet-activating factor receptor contain two consecutive basic amino acids (KK) at the juxtamembrane position in the COOH terminus (39) . However, it is noteworthy that the protease-activated receptor 4 lacks the doublet of basic amino acids in the COOH terminus (51) , suggesting that the BB motif is not always required for G q coupling.
In conclusion, we have shown that the Arg333 and Arg334 residues in the COOH terminus of the P2Y 1 receptor are important for the G protein coupling. This is the first report of the identification of an important region and residues in the P2 receptor family for G protein coupling.
